Stock Analysis

How Paycom’s Mixed Q3, CFO Sale and Recurring Revenue Momentum At Paycom Software (PAYC) Has Changed Its Investment Story

  • In the past week, Paycom Software reported third-quarter 2025 results that slightly missed earnings per share forecasts but exceeded revenue expectations, while its CFO Robert D. Foster sold 1,300 shares for about US$211,458 and the company presented at Barclays’ Global Technology Conference in San Francisco on December 10.
  • Analysts at Needham reinforced their Hold rating after these updates, highlighting accelerating recurring revenue growth and a constructive outlook for Paycom’s performance into the fourth quarter and 2026.
  • We’ll now examine how the earnings surprise and Needham’s commentary on recurring revenue growth may reshape Paycom’s existing investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 25 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Paycom Software Investment Narrative Recap

To own Paycom, you need to believe its unified HR and payroll platform and AI tools like IWant can keep driving sticky, recurring revenue even as competition in HCM software intensifies. The latest quarter’s slight EPS miss alongside recurring revenue outperformance does not materially change the near term catalyst, which is continued adoption and monetization of its AI driven features, or the key risk that rising AI and infrastructure spending could weigh on margins if usage scales faster than efficiency gains.

The most relevant recent development here is Needham’s reaffirmed Hold rating after Q3 2025, paired with its focus on accelerating recurring revenue growth. That external read-through matters because Paycom’s core catalyst is the platform’s ability to convert AI powered engagement into durable, subscription like revenue, especially as the company keeps investing heavily in infrastructure and R&D while absorbing a weaker share price and ongoing buybacks.

Yet while recurring revenue momentum looks encouraging, investors still need to be aware of how sustained AI infrastructure spending could...

Read the full narrative on Paycom Software (it's free!)

Paycom Software's narrative projects $2.5 billion revenue and $586.5 million earnings by 2028. This requires 8.1% yearly revenue growth and about a $170.8 million earnings increase from $415.7 million today.

Uncover how Paycom Software's forecasts yield a $209.94 fair value, a 26% upside to its current price.

Exploring Other Perspectives

PAYC 1-Year Stock Price Chart
PAYC 1-Year Stock Price Chart

Four members of the Simply Wall St Community currently see Paycom’s fair value between about US$209.94 and US$377.56, highlighting very different expectations. As you weigh those views, keep in mind that the key catalyst many are watching is whether Paycom’s AI products can truly translate into durable recurring revenue growth in a market where switching costs may be falling.

Explore 4 other fair value estimates on Paycom Software - why the stock might be worth over 2x more than the current price!

Build Your Own Paycom Software Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

Looking For Alternative Opportunities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

The New Payments ETF Is Live on NASDAQ:

Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.

Explore how this launch could reshape portfolios

Sponsored Content

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:PAYC

Paycom Software

Provides cloud-based human capital management (HCM) solution delivered as software-as-a-service for small to mid-sized companies in the United States.

Very undervalued with flawless balance sheet.

Weekly Picks

WO
MGPI logo
woodworthfund on MGP Ingredients ·

THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Fair Value:US$4034.1% undervalued
22 users have followed this narrative
1 users have commented on this narrative
5 users have liked this narrative
DO
Double_Bubbler
EVTL logo
Double_Bubbler on Vertical Aerospace ·

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

Fair Value:US$6089.9% undervalued
22 users have followed this narrative
2 users have commented on this narrative
17 users have liked this narrative
TI
TickerTickle
ORCL logo
TickerTickle on Oracle ·

The Quiet Giant That Became AI’s Power Grid

Fair Value:US$389.8149.0% undervalued
43 users have followed this narrative
3 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Unicycive Therapeutics (Nasdaq: UNCY) – Preparing for a Second Shot at Bringing a New Kidney Treatment to Market (TEST)

Fair Value:US$21.5370.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KI
RKLB logo
KiwiInvest on Rocket Lab ·

Rocket Lab USA Will Ignite a 30% Revenue Growth Journey

Fair Value:US$97.8335.1% undervalued
137 users have followed this narrative
8 users have commented on this narrative
0 users have liked this narrative
BA
Bauyrzhan
DG logo
Bauyrzhan on Dollar General ·

Dollar general to grow

Fair Value:US$158.916.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
120 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3927.7% undervalued
963 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8688.0% undervalued
78 users have followed this narrative
8 users have commented on this narrative
21 users have liked this narrative